Dachaigh › Ailse a' Chinn agus a' Mhuineil › Utah
Sgrùdaidhean clionaigeach Ailse a' Chinn agus a' Mhuineil ann an Utah
Tha 7 sgrùdaidhean airson Ailse a' Chinn agus a' Mhuineil a’ lorg phàirtichean aig làraichean ann an Utah.
Bailtean ann an Utah
Teacsa sgrùdaidh oifigeil (Beurla)
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 4, West Valley City
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07085091A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Huntsman Cancer Institute, Salt Lake City
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07020117Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment
- University of Utah, Salt Lake City
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT06108089First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT05768139Improving Care for Rural Patients With Solid Tumors
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
A’ fastadh
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 5 Gearr 2026 · NCT04916990VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Utah Cancer Specialists (site 203), Salt Lake City
A’ fastadhÌre 1/2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 11 Dùbh 2025 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.